Drug Profile
Research programme: anti-infectives - MicuRx Pharmaceuticals
Alternative Names: Antibacterials – MicuRx Pharmaceuticals; Antifungals – MicuRx Pharmaceuticals; MRX-IILatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator MicuRx Pharmaceuticals
- Class Oxazolidinones
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gram-positive infections; Mycoses
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Gram-positive-infections in China (IV)
- 04 Nov 2017 No recent reports of development identified for research development in Gram-positive-infections in China (PO)
- 04 Nov 2017 No recent reports of development identified for research development in Gram-positive-infections in USA (IV)